VYNE VYNE Therapeutics Inc.

Healthcare

$0.68+0.00%OpenMarket Cap: $11.4M

As of 2026-05-26

Analyst Consensus

Consensus

Hold

Target (Consensus)

$5.75

Target (Median)

$5.75

Target Range

$5.75 - $5.75

Upside from current price: 741.9%

0 Strong Buy1 Buy2 Hold0 Sell0 Strong Sell

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2025-07-30	HC Wainwright & Co.	downgrade	Neutral	Buy

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Thu Dec 31	$-0.59	$350.0K	1
Fri Dec 31	$-0.64	$10.3M	1
Sun Dec 31	$-0.64	$13.6M	1
Mon Dec 31	$-2.65	$50.0M	1